L. Wang

A phase II study of cediranib (AZD2171) in recurrent or persistent ovarian, peritoneal or fallopian tube cancer: Final results of a PMH, Chicago and California consortia trial

Hal W. Hirte, Liat Vidal, Gini F. Fleming et al. · Journal of Clinical Oncology · 2008 · 83 citations

Medicine, Pharmacology, Pharmacotherapy +17

A phase 2 study of cediranib in recurrent or persistent ovarian, peritoneal or fallopian tube cancer: A trial of the Princess Margaret, Chicago and California Phase II Consortia

Hal W. Hirte, Stéphanie Lheureux, Gini F. Fleming et al. · Gynecologic Oncology · 2015 · 75 citations

Medicine, Gynecology, Oncology +11

A phase II study of GW786034 (pazopanib) in patients with recurrent or metastatic invasive breast carcinoma: Results after completion of stage I: A trial of the Princess Margaret Hospital Phase II Consortium

Sara Taylor, S. Chia, Susan Dent et al. · Journal of Clinical Oncology · 2009 · 16 citations

Medicine, Oncology, Pharmacology +17

Phase I study of E7389/gemcitabine combination in patients with advanced solid tumors

Rakesh Goel, E. Chen, Stephen Welch et al. · Journal of Clinical Oncology · 2009 · 10 citations

Medicine, Oncology, Pharmacology +15